Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind phase III trial of pazopanib versus placebo in soft tissue sarcoma
2008-001307-33Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in soft tissue sarcoma (STS) comparing Pazopanib with Placebo (2 arms). Primary endpoint: Overall progression-free survival. Started Jul 2008; status: completed.
02
Drugs
pazopanib
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on 2008-001307-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001307-33.